Navigation Links
Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures

EAST HANOVER, N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the May 2007 release of a New England Journal of Medicine (NEJM) report that Avandia users are 43 percent more likely to suffer a heart attack and 67 percent more likely to die of cardiovascular causes than non-users of Avandia, it is no surprise that physicians intend to switch many type 2 diabetes patients from Avandia to therapies believed to pose less risk. Research from GfK Market Measures' Event Flash, Physicians' Reactions to NEJM's Results on Avandia's Increased CV Risk, suggests, however, a greater negative response by internists than endocrinologists.

The GfK Market Measures study showed universal awareness of the NEJM report, though not all physicians recalled the exact percentages. The internists, however, demonstrated the strongest negative impact to the findings signaling they will "switch more than half their patients currently on Avandia to another therapy," according to Anna Marie Napolitano, Vice President and Leader of GfK Market Measures' Cardiology Practice. "This sharply contrasts with general/family practitioners and endocrinologists who expect to switch less than half of their patients."

Forty percent of internists also indicated a high likelihood they will take all of their Avandia, Avandamet and Avandaryl patients off each respective drug, even though the FDA has not required it, in contrast to a smaller percentage of endocrinologists. Internists are also more likely than the endocrinologists to indicate a reluctance to prescribe any product containing Avandia.

To a lesser degree, the news of Avandia's effect on cardiovascular risk may have negatively impacted physicians' perceptions of ACTOS. One-third of internists and about one-quarter of general/family practitioners and endocrinologists report they are reluctant to prescribe ACTOS or any other product containing ACTOS (i.e., ACTOplus met).

The GfK Market
'"/>




Page: 1 2 3

Related medicine technology :

1. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
2. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
3. FDA Issues Safety Alert on Avandia
4. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
5. Data Show FluMist May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
6. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/22/2014)... Ill. , July 22, 2014  UL ... announced that the U.S. Food and Drug Administration ... as consensus standards for medical devices incorporating lithium ... 2054 - Standard for Household and Commercial Batteries, ... (Cells). Consensus standards are standards ...
(Date:7/22/2014)... N.J. , July 22, 2014  Vernalis plc ... achievement of proof-of-concept (POC) for CCP-08, the third ... prescription cough cold collaboration. Under this collaboration, POC ... a successful human pilot comparative study against an ... achieving POC, Vernalis will make a milestone payment ...
(Date:7/22/2014)... SAN MARCOS, Texas , July 22, 2014 Quantum ... Martin and Mr. John Heaton to the Board ... chaired by Dr. Ghassan Jabbour , QMC Chief Science Officer ... Dr. Michael Wong of Rice University and Mr. ... Japan . " Quantum Materials ...
Breaking Medicine Technology:Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... Bowl champion coach, Fox NFL Sunday host and ... ExtenZe, the male enhancement brand, he has good-naturedly taken a ... national television. Now, in this next flight of ... fun, laughing about being put on the spot and made ...
... AMGN ) today announced that results from ... be presented at the 35th European Society for Medical ... "Cancer is a complex disease which ... pathways to develop novel therapies to treat cancer and ...
Cached Medicine Technology:Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His 'Notoriety' in New ExtenZe Spots from Inter/Media Advertising 2Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His 'Notoriety' in New ExtenZe Spots from Inter/Media Advertising 3Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 2Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 3Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 4Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 5Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 6Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 7Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 8Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 9Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 10Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 11Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 12Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 13Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 14Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 15Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress 16
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 The ... to increase in size through 2022, according to new ... improve their appearance can benefit from a new guide ... review for women is now available at http://cherrynews.com/best-nourishing-eye-serum ... and includes instant links to many of the top ...
(Date:7/22/2014)... Campbell, CA (PRWEB) July 22, 2014 ... along with his surgical colleagues, have recently discussed the ... implants. Many leaders in the periodontics profession are seeing ... implants go up exponentially. In fact, one surgeon reported ... treat failing implants. Although dental implants have a very ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... treatments that break up blood clots deep in the veins ... risk. However, one results in a greater risk of bleeding ... of the other treatment, a new study finds. The ... thrombosis (DVT) -- is blood-thinning medications and compression stockings. The ...
(Date:7/22/2014)... Club you eat pretty much everything you put on ... University study shows that the average adult eats 92% of ... plate. "If you put it on your plate, it,s ... the forthcoming book, Slim by Design, Professor of Marketing and ... and co-author Katherine Abowd Johnson analyzed 1179 diners and concluded ...
(Date:7/22/2014)... 22, 2014 As reported on July 17, ... request to name her favorite beauty products, “ Botox , ... say that “ Botox has changed my life” by ... chair preparing for her various, daily appearances. “Suddenly my ... Ripa (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s response ...
Breaking Medicine News(10 mins):Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2
... Public Health have found the first evidence that perfluorinated ... in everyday items such as food packaging, pesticides, clothing, ... associated with infertility in women. , ... reproductive medicine journal, the study found that women who ...
... Omaha-based SimplyWell will be presented to President ... health care in the United States.Former Speaker of the House ... hosted a special event January 26 at the National Press ... of Finding What Works." Joined by a ...
... 30 Meijer initiated a voluntary,recall of two types of ... ice cream novelties sold in all of its stores in ... from,its stores and gas stations. All sell-by dates are impacted ... has recalled the following items:, -- Meijer ...
... sugary fare may be to blame, researchers say , , ... TV more than five hours a day are prone ... suggests. , The connection? Too much time spent watching ... food choices, University of Minnesota researchers say. , "Television ...
... Jan. 30 Turner Construction Company, the nation,s ... the $323 million state-of-the-art Greenfield replacement hospital for ... manager for the project that is scheduled for ... advanced technologies in order to ensure quality clinical ...
... the American Heart Association recommends that omega-6 polyunsaturated fatty ... seeds, are beneficial when part of a heart-healthy eating ... energy (calories) from omega-6 PUFAs, and will derive most ... in the diet. Precise recommended daily servings will depend ...
Cached Medicine News:Health News:Household chemicals may be linked to infertility 2Health News:Household chemicals may be linked to infertility 3Health News:Applying the Obama Test to Healthcare: SimplyWell Cited as Top 10 Best Practices by Center for Healthcare Transformation 2Health News:Meijer Announces Voluntary Recall for Some Meijer Brand Peanuts and Ice Cream Novelties Citing Possible Health Risk 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 3Health News:Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J. 2Health News:Omega-6 PUFAs and risk of cardiovascular disease 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: